However, the removal of CD4+ T cells in WEHI-164 tumor-bearing mice totally abrogated the therapeutic effects of G-G schedule treatment, thus suggesting the importance of the CD4+ Th-cell compartment in the immune rejection of this tumor histotype, as was previously demonstrated in the case of L-M therapy 11 (Fig. 2A). This evidence concerns the gene CD4 and neoplasm.